DRug Use and Infections in Hai Phong ViEtnam Among Persons Who Inject Drugs

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

5546 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-10-17

Study Completion Date

2020-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overarching purpose of the proposed research is to demonstrate that high coverage implementation of combined prevention and care using an innovative approach will end the HIV epidemic among PWID in Haiphong, Viet Nam.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Scaling up an Evidence-based Intervention for Antiretroviral Therapy for PWID in Vietnam: an Implementation Trial

NCT03952520

HIV Infections Drug Use

COMPLETED NA

A Spatial Analysis of Hotspots and Targeted Injection Settings Pilot Intervention for HIV Prevention Among People Who Inject Drugs

NCT05769023

COVID-19

ENROLLING_BY_INVITATION NA

Development of a Family Intervention to Address Drug Use and HIV in Vietnam

NCT01540188

Quality of Life

COMPLETED PHASE1/PHASE2

Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE)

NCT01122186

HIV Medication Adherence Methamphetamine Use Sexual Risk +2 more

COMPLETED NA

Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China

NCT00346762

HIV Infections

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Injection drug use is driving HIV epidemics in low/middle-income countries in Eastern Europe, Central Asia and Southeast Asia. "Combined prevention and care", including needle/syringe programs (NSP), medication-assisted treatment for opiate dependence, and antiretroviral treatment, has greatly reduced HIV incidence among persons who inject drugs (PWID) in many high-income areas, to where the "HIV epidemics" among PWID have "ended." There is now the need for a convincing demonstration that an HIV epidemic can be ended in a low/middle income setting. The overarching purpose of the proposed research is to demonstrate that high coverage implementation of combined prevention and care using an innovative approach will end the HIV epidemic among PWID in Haiphong, Viet Nam. The researchers define "ending the epidemic" as reducing HIV incidence to 0.5/100 person-years at risk.

Data collection will include recruitment using repeated community based respondent driven sampling (RDS) surveys, once per year among PWID in Hai Phong. Participants will be given a quantitative questionnaire and tested for HIV and Hepatitis C (HCV). Peer support groups will be mobilized to help recruit PWID and assist in educations on the benefits of early ART, access to methadone, antiretroviral treatment and psychiatric services, and ways to prevent HIV and HCV transmission through safe injection practices and safe sex. Additionally, the investigators will develop large cohorts of HIV positive and HIV negative PWID to closely document behaviors trends, HIV incidence, and the obstacles of the access and retention in HIV care and methadone. It has been shown that it is possible to end HIV epidemics among PWID in several high income countries. This study will build upon the knowledge and results gained in high income settings to achieve viral suppression among HIV positive PWID and reduce HIV/HCV incidence in order to "end the HIV epidemic" among persons who inject drugs in Haiphong.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Hepatitis C Mental Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HIV negative from RDS round 1

HIV negative PWID subjects from RDS round 1

No interventions assigned to this group

HIV negative from RDS round 2

HIV negative PWID subjects from RDS round 2

No interventions assigned to this group

HIV negative from RDS round 3

HIV negative PWID subjects from RDS round 3

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18 or older
* capable of giving informed consent and participating in study activities
* history of drug injection (confirmed by visual inspection or subject knowledge of injecting procedures)
* currently using an injectable drug (heroin or methamphetamine
* confirmed by urine test), not on MMT at initial recruitment
* willingness to participate in follow up studies, and expecting to remain in Haiphong for 2 years

Exclusion Criteria

* less than 18 years of age
* on MMT at initial recruitment
* refusal to participate in follow-up studies
* no history of drug injection
* not currently using injectable drug (heroin or methamphetamine)
* not capable of giving informed consent
* those not expecting to remain in Haiphong for at least 2 years

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No